<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02779660</url>
  </required_header>
  <id_info>
    <org_study_id>RIPPAF V1</org_study_id>
    <nct_id>NCT02779660</nct_id>
  </id_info>
  <brief_title>Effect of Remote Ischemic Preconditioning on Electrophysiological and Biomolecular Parameters in Non-valvular Paroxysmal Atrial Fibrillation: RIPPAF Study</brief_title>
  <acronym>RIPPAF</acronym>
  <official_title>Effect of Remote Ischemic Preconditioning on Electrophysiological and Biomolecular Parameters in Non-valvular Paroxysmal Atrial Fibrillation: RIPPAF Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Jedrzej Kosiuk</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Heartcenter Leipzig GmbH</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to examine the effect of RIPC on physiological parameters in
      non-valvular paroxysmal atrial fibrillation. Furthermore the study will provide a unique
      bio-date base for further analysis of molecular and genetic mechanisms responsible for
      observed results.

      The potential effect of RIPC on AF inducibility and/or prothrombotic activity might be
      implemented as additional treatment component to reduce AF burden and minimize thromboembolic
      risk.

      Interim Analysis will be done after 73 patients.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2016</start_date>
  <completion_date type="Anticipated">September 2018</completion_date>
  <primary_completion_date type="Anticipated">May 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>inducibility of Atrial Fibrillation by high-rate pacing of 20 s</measure>
    <time_frame>during the Atrial Fibrillation Ablation procedure</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>sustainability of Atrial Fibrillation measured in seconds</measure>
    <time_frame>during the Atrial Fibrillation Ablation procedure</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">146</enrollment>
  <condition>Atrial Fibrillation</condition>
  <arm_group>
    <arm_group_label>RIPC-Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>After randomization patients will undergo 3 sessions of RIPC (Remote ischemic preconditioning) intervention: I) on preoperative day, II) 1 h before and III) directly before the blood sample collection and invasive measurement of electrophysiological parameters.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control-Group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>After randomization patients will undergo 3 sessions of sham-intervention: I) on preoperative day, II) 1 h before and III) directly before the blood sample collection and invasive measurement of electrophysiological parameters.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Remote ischemic preconditioning (RIPC)</intervention_name>
    <description>RIPC will be induced by the application of 3 short episodes (5 minutes) of forearm ischemia by cuff sphygmomanometer inflation separated by 5 minutes of reperfusion.</description>
    <arm_group_label>RIPC-Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>sham-intervention</intervention_name>
    <description>In the control group the cuff will be inflated for 3 times at 10 mm Hg for 5 minutes with 5-minute intervals</description>
    <arm_group_label>Control-Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  planned invasive Atrial Fibrillation ablation

        Exclusion Criteria:

          -  AF in ECG at Admission

          -  history of AF ablation

          -  age &lt;18

          -  pregnancy

          -  neoplastic disorders

          -  acute or systemic inflammation, autoimmune diseases

          -  documented atrial flutter
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jedrzej Kosiuk, MD</last_name>
    <email>Jedrzej.Kosiuk@helios-kliniken.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>Herzzentrum Leipzig</name>
      <address>
        <city>Leipzig</city>
        <zip>04289</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jedrzej Kosiuk</last_name>
      <email>Jedrzej.Kosiuk@helios-kliniken.de</email>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 12, 2016</study_first_submitted>
  <study_first_submitted_qc>May 19, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 20, 2016</study_first_posted>
  <last_update_submitted>August 17, 2017</last_update_submitted>
  <last_update_submitted_qc>August 17, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 22, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Heartcenter Leipzig GmbH</investigator_affiliation>
    <investigator_full_name>Jedrzej Kosiuk</investigator_full_name>
    <investigator_title>MD Jedrzej Kosiuk</investigator_title>
  </responsible_party>
  <keyword>Atrial Fibrillation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

